Alivus Life Sciences Ltd header image

Alivus Life Sciences Ltd

543322

Equity

ISIN INE03Q201024 / Valor 112824626

Bombay Stock Exchange Ltd. (Mumbai) (2026-11-06)
INR 1,480.55-1.12%

Alivus Life Sciences Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alivus Life Sciences Ltd is a life‑sciences company focused on developing and bringing biomedical technologies and services to the healthcare market. Its operations typically span early‑stage research and development through productization, with activities that can include preclinical and clinical programs, diagnostic or therapeutic product development, and provision of research or manufacturing services to partners. The company’s commercial strategy is built around developing proprietary intellectual property, pursuing necessary regulatory clearances, and generating revenue through product sales, service contracts and strategic collaborations or licensing agreements to scale distribution into clinical, laboratory and specialist care channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

66.0%1Y
139%3Y
135%5Y

Performance

28.3%1Y
35.7%3Y
32.5%5Y

Volatility

Market cap

1936 M

Market cap (USD)

Daily traded volume (Shares)

66,972

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%EUR 148.75
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 37.43
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330445
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%EUR 77.40
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.53%EUR 103.20
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.78%CHF 133.61
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.68%CHF 257.60
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.32%CHF 89.45
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%CHF 56.80
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.05%CHF 109.60
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%CHF 71.00